Security key
45781K204
- Security type / class
- Equity / SPONSORED ADS
- Total 13F shares
- 1,281,081
- Total 13F value
- $5,847,000
- Share change
- +337,967
- SEC-reported price per share
- $4.56
- Number of holders
- 15
- Value change
- +$940,213
- Number of buys
- 8
- Number of sells
- 13
Report period
Q4 2021
Institutions
15
Top holders
10
IPHA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Innate Pharma SA SEC filings
Innate Pharma SA company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45781K204
Recent filing periods:
Ownership snapshot
Top reported holders of IPHA - Innate Pharma SA - SPONSORED ADS (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BALYASNY ASSET MANAGEMENT...
Disclosed value leader
BALYASNY ASSET MANAGEMENT...
Comparable rows
0/15
Latest evidence
30 Sep 2021
13F
Highest disclosed value: $1,157,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BALYASNY ASSET MANAGEMENT L.P. has the largest disclosed position value at $1.16M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BALYASNY ASSET MANAGEMENT L.P.'s linked filing trail.
Disclosed position value
Top 5
BALYASNY ASSET MANAGEMENT L.P.
$1.16M
BANK OF AMERICA CORP /DE/
$1.07M
Affinity Asset Advisors, LLC
$771K
Virtu Financial LLC
$676K
Optiver Holding B.V.
$673K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. |
13F
Company
|
—
denominator unverified
|
$1,157,000
187,484 shares
|
— | 30 Sep 2021 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
—
denominator unverified
|
$1,074,000
174,100 shares
|
— | 30 Sep 2021 |
| Affinity Asset Advisors, LLC |
13F
Company
|
—
denominator unverified
|
$771,000
125,000 shares
|
— | 30 Sep 2021 |
| Virtu Financial LLC |
13F
Company
|
—
denominator unverified
|
$676,000
109,572 shares
|
— | 30 Sep 2021 |
| Optiver Holding B.V. |
13F
Company
|
—
denominator unverified
|
$673,000
109,039 shares
|
— | 30 Sep 2021 |
| PURA VIDA INVESTMENTS, LLC |
13F
Company
|
—
denominator unverified
|
$509,000
82,509 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
15
Shares
1,281,081
Rows available
15
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q2 2026 Across Filers
Q2 2026 holders
10
Q4 2021 holders
15
Holder diff
5
| Investor | Q2 2026 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q2 2026 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend